Sherene Loi, MBBS (Hons), PhD, FRACP, FAHMS, GAICD, will lead a panel discussion on Wednesday afternoon about the winding road of immune biomarkers in early breast cancer.

Ismail Jatoi, MD, PhD, will moderate a Wednesday afternoon risk reduction and early detection session on updates in breast cancer screening.

Antonio Wolff, MD, will moderate a Wednesday afternoon session on questions that will inform clinical trial design and guide treatment decisions.

San Antonio Breast Cancer Symposium® Co-Directors Carlos Arteaga, MD, and Virginia Kaklamani, MD, share a message for the thousands of attendees joining the SABCS® in person and virtually this week.

Plan your Tuesday schedule and don’t miss notable items on the program, including concurrent Special Sessions and Educational Sessions that address hot topics in breast cancer.